|
Recent Newsletters
Helping cardiologists communicate | FDA clears new Abbott device | Statins & chemotherapy side effects |
The first procedure of its kind in US | Abbott's big recall | ChatGPT | Quality in ASCs | More from the last week |
Vascular & Endovascular Highlights: Blood thinner recalled due to cancer risk | Intravascular imaging-guided PCI |
SCAI blasts Medicare payment cuts | Cardiologists make history, performing first procedure of its kind in US |
TAVR Highlights: New valves focus on commissural alignment | AI predicts common complication | Much more |
ChatGPT's usefulness in cardiology put to the test | What is the ROI for upgrading nuclear cardiology labs? |
Structural Heart Disease Highlights: A close look at the TRILUMINATE trial | Key research in interventional cardiology |